-
Je něco špatně v tomto záznamu ?
Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy
R. Coppo, L. Peruzzi, E. Loiacono, M. Bergallo, A. Krutova, ML. Russo, E. Cocchi, A. Amore, S. Lundberg, D. Maixnerova, V. Tesar, A. Perkowska-Ptasińska, M. Durlik, D. Goumenos, M. Gerolymos, K. Galesic, L. Toric, A. Papagianni, M. Stangou, M....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
PubMed
29635535
DOI
10.1093/ndt/gfy064
Knihovny.cz E-zdroje
- MeSH
- antigeny CD46 krev genetika MeSH
- biologické markery krev MeSH
- dospělí MeSH
- IgA nefropatie krev diagnóza genetika MeSH
- inhibitory komplementu krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA krev genetika MeSH
- prognóza MeSH
- progrese nemoci MeSH
- regulace genové exprese MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Complement is thought to play a role in immunoglobulin A nephropathy (IgAN), though the activating mechanisms are unknown. This study focused on the gene expression of CD46 and CD55, two key molecules for regulating C3 convertase activity of lectin and alternative complement pathways at a cellular level. METHODS: The transcriptional expression in peripheral white blood cells (WBCs) of CD46 and CD55 was investigated in 157 patients enrolled by the Validation of the Oxford Classification of IgAN group, looking for correlations with clinical and pathology features and estimated glomerular filtration rate (eGFR) modifications from renal biopsy to sampling. Patients had a previous median follow-up of 6.4 (interquartile range 2.8-10.7) years and were divided into progressors and non-progressors according to the median value of their velocity of loss of renal function per year (-0.41 mL/min/1.73 m2/year). RESULTS: CD46 and CD55 messenger RNA (mRNA) expression in WBCs was not correlated with eGFR values or proteinuria at sampling. CD46 mRNA was significantly correlated with eGFR decline rate as a continuous outcome variable (P = 0.014). A significant difference was found in CD46 gene expression between progressors and non-progressors (P = 0.013). CD46 and CD55 mRNA levels were significantly correlated (P < 0.01), although no difference between progressors and non-progressors was found for CD55 mRNA values. The prediction of progression was increased when CD46 and CD55 mRNA expressions were added to clinical data at renal biopsy (eGFR, proteinuria and mean arterial blood pressure) and Oxford MEST-C (mesangial hypercellularity, endocapillary hypercellularity, segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis, presence of any crescents) score. CONCLUSIONS: Patients with progressive IgAN showed lower expression of mRNA encoding for the complement inhibitory protein CD46, which may implicate a defective regulation of C3 convertase with uncontrolled complement activation.
Department of Nephrology and Transplantation Medicine Wroclaw Medical University Wroclaw Poland
Department of Nephrology Borgomanero Hospital Borgomanero Italy
Department of Nephrology Dialysis and Transplantation Regina Margherita Hospital Turin Italy
Department of Nephrology Dubrava University Hospital Zagreb Croatia
Department of Nephrology Emergency and Transplantation University of Bari Bari Italy
Department of Nephrology University Hospital of Patras Patras Greece
Department of Pediatrics and Nephrology Medical University of Warsaw Warsaw Poland
Department of Pediatrics Regional Children's Clinical Hospital Vladivostok Russia
Department of Public Health and Pediatric Sciences University of Turin Turin Italy
Department of Transplantation Medicine and Nephrology Medical University of Warsaw Warsaw Poland
Fondazione Ricerca Molinette Regina Margherita Hospital Turin Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006831
- 003
- CZ-PrNML
- 005
- 20200518133044.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ndt/gfy064 $2 doi
- 035 __
- $a (PubMed)29635535
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Coppo, Rosanna $u Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
- 245 10
- $a Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy / $c R. Coppo, L. Peruzzi, E. Loiacono, M. Bergallo, A. Krutova, ML. Russo, E. Cocchi, A. Amore, S. Lundberg, D. Maixnerova, V. Tesar, A. Perkowska-Ptasińska, M. Durlik, D. Goumenos, M. Gerolymos, K. Galesic, L. Toric, A. Papagianni, M. Stangou, M. Mizerska-Wasia Membek, L. Gesualdo, E. Montemurno, L. Benozzi, S. Cusinato, T. Hryszko, M. Klinger, D. Kamińska, M. Krajewska, VALIGA Study Group of the ERA-EDTA Immunonephrology Working Group,
- 520 9_
- $a BACKGROUND: Complement is thought to play a role in immunoglobulin A nephropathy (IgAN), though the activating mechanisms are unknown. This study focused on the gene expression of CD46 and CD55, two key molecules for regulating C3 convertase activity of lectin and alternative complement pathways at a cellular level. METHODS: The transcriptional expression in peripheral white blood cells (WBCs) of CD46 and CD55 was investigated in 157 patients enrolled by the Validation of the Oxford Classification of IgAN group, looking for correlations with clinical and pathology features and estimated glomerular filtration rate (eGFR) modifications from renal biopsy to sampling. Patients had a previous median follow-up of 6.4 (interquartile range 2.8-10.7) years and were divided into progressors and non-progressors according to the median value of their velocity of loss of renal function per year (-0.41 mL/min/1.73 m2/year). RESULTS: CD46 and CD55 messenger RNA (mRNA) expression in WBCs was not correlated with eGFR values or proteinuria at sampling. CD46 mRNA was significantly correlated with eGFR decline rate as a continuous outcome variable (P = 0.014). A significant difference was found in CD46 gene expression between progressors and non-progressors (P = 0.013). CD46 and CD55 mRNA levels were significantly correlated (P < 0.01), although no difference between progressors and non-progressors was found for CD55 mRNA values. The prediction of progression was increased when CD46 and CD55 mRNA expressions were added to clinical data at renal biopsy (eGFR, proteinuria and mean arterial blood pressure) and Oxford MEST-C (mesangial hypercellularity, endocapillary hypercellularity, segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis, presence of any crescents) score. CONCLUSIONS: Patients with progressive IgAN showed lower expression of mRNA encoding for the complement inhibitory protein CD46, which may implicate a defective regulation of C3 convertase with uncontrolled complement activation.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a inhibitory komplementu $x krev $7 D051056
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a IgA nefropatie $x krev $x diagnóza $x genetika $7 D005922
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a antigeny CD46 $x krev $x genetika $7 D051916
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a messenger RNA $x krev $x genetika $7 D012333
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Peruzzi, Licia $u Department of Nephrology, Dialysis and Transplantation, Regina Margherita Hospital, Turin, Italy.
- 700 1_
- $a Loiacono, Elisa $u Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
- 700 1_
- $a Bergallo, Massimilano $u Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
- 700 1_
- $a Krutova, Alexandra $u Department of Pediatrics, Regional Children's Clinical Hospital, Vladivostok, Russia.
- 700 1_
- $a Russo, Maria Luisa $u Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
- 700 1_
- $a Cocchi, Enrico $u Department of Nephrology, Dialysis and Transplantation, Regina Margherita Hospital, Turin, Italy.
- 700 1_
- $a Amore, Alessandro $u Department of Nephrology, Dialysis and Transplantation, Regina Margherita Hospital, Turin, Italy.
- 700 1_
- $a Lundberg, Sigrid $u Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Maixnerova, Dita $u Department of Nephrology, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Perkowska-Ptasińska, Agnieszka $u Department of Transplantation Medicine and Nephrology, Medical University of Warsaw, Warsaw, Poland.
- 700 1_
- $a Durlik, Magdalena $u Department of Transplantation Medicine and Nephrology, Medical University of Warsaw, Warsaw, Poland.
- 700 1_
- $a Goumenos, Dimitris $u Department of Nephrology, University Hospital of Patras, Patras, Greece.
- 700 1_
- $a Gerolymos, Miltiadis $u Department of Nephrology, University Hospital of Patras, Patras, Greece.
- 700 1_
- $a Galesic, Kresimir $u Department of Nephrology, Dubrava University Hospital, Zagreb, Croatia.
- 700 1_
- $a Toric, Luka $u Department of Nephrology, Dubrava University Hospital, Zagreb, Croatia.
- 700 1_
- $a Papagianni, Aikaterini $u Department of Nephrology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- 700 1_
- $a Stangou, Maria $u Department of Nephrology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- 700 1_
- $a Mizerska-Wasia Membek, Malgorzata $u Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.
- 700 1_
- $a Gesualdo, Loreto $u Department of Nephrology, Emergency and Transplantation, University of Bari, Bari, Italy.
- 700 1_
- $a Montemurno, Eustacchio $u Department of Nephrology, Emergency and Transplantation, University of Bari, Bari, Italy.
- 700 1_
- $a Benozzi, Luisa $u Department of Nephrology, Borgomanero Hospital, Borgomanero, Italy.
- 700 1_
- $a Cusinato, Stefano $u Department of Nephrology, Borgomanero Hospital, Borgomanero, Italy.
- 700 1_
- $a Hryszko, Tomasz $u Department of Nephrology, Transplantation and Dialysis, Medical University of Bialystok, Bialystok, Poland.
- 700 1_
- $a Klinger, Marian $u Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
- 700 1_
- $a Kamińska, Dorota $u Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
- 700 1_
- $a Krajewska, Magdalena $u Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
- 710 2_
- $a VALIGA Study Group of the ERA-EDTA Immunonephrology Working Group
- 773 0_
- $w MED00010288 $t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 34, č. 4 (2019), s. 587-596
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29635535 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518133043 $b ABA008
- 999 __
- $a ok $b bmc $g 1525689 $s 1096887
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 34 $c 4 $d 587-596 $e 20190401 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
- LZP __
- $a Pubmed-20200511